Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pharmacogenet Genomics. 2017 Jun;27(6):213–222. doi: 10.1097/FPC.0000000000000281

Table 3. Multivariable regression analysis of the association between COMT and TPMT polymorphisms and cisplatin-induced ototoxicity using CTCAE grading as an ordinal outcome.

Estimate (SE) Overall P-value Bonferroni corrected P- value

COMT rs9332377 (CC)

Grade 1 vs Grade 0: 1.03 (0.72)
Grade 2 vs Grade 0: 0.19 (0.53) 0.30 1.00
Grade 3 vs Grade 0: -0.54 (0.60)
Grade 4 vs Grade 0: 0.47 (0.76)

COMT rs4646316 (CC)

Grade 1 vs Grade 0: 0.52 (0.77)
Grade 2 vs Grade 0: -0.10 (0.56) 0.93 1.00
Grade 3 vs Grade 0: 0.079 (0.59)
Grade 4 vs Grade 0: -0.24 (0.94)

TPMT rs12201199 (AA)

Grade 1 vs Grade 0: -1.07 (1.12)
Grade 2 vs Grade 0: -0.92 (0.65) 0.068 0.34
Grade 3 vs Grade 0: -1.66 (0.78)
Grade 4 vs Grade 0: -17.6 (2940)

TPMT rs1142345 (TT)

Grade 1 vs Grade 0: -0.47 (1.10)
Grade 2 vs Grade 0: -0.43 (0.70) 0.55 1.00
Grade 3 vs Grade 0: -0.72 (0.83)
Grade 4 vs Grade 0: -16.9 (3450)

TPMT rs1800460 (CC)

Grade 1 vs Grade 0: -0.041 (1.10)
Grade 2 vs Grade 0: -0.13 (0.78) 0.83 1.00
Grade 3 vs Grade 0: -0.23 (0.96)
Grade 4 vs Grade 0: -16.4 (3990)

Analysis undertaken using worse ear grade (in cases of asymmetric hearing loss)